Bio-Rad Laboratories Inc. Class A Common Stock [BIO]
The TickerPaging button is a members-only feature. (Million)
Annual Financial Data
| Date | Revenue | NetIncome | Operating CF | Assets | Equity |
|---|
| 2017/12 | 2,160.15 | 122.25 | 103.89 | 4,273.01 | 2,930.25 |
| 2018/12 | 2,289.4 | 365.61 | 285.49 | 5,611.07 | 4,020.33 |
| 2019/12 | 2,311.7 | 1,758.67 | 457.9 | 8,008.86 | 5,755.06 |
| 2020/12 | 2,545.6 | 3,806.27 | 575.33 | 12,972.62 | 9,879.94 |
| 2021/12 | 2,922.5 | 4,245.9 | 656.52 | 17,775.79 | 13,667.13 |
Annual Indicators
| Date | Stock Price | BPS | PBR | EPS（Annual） | PER（Annual） |
|---|
| 2017/12 | 238.67 | 98.81 | 2.42 | 4.07 | 58.64 |
| 2018/12 | 232.22 | 134.75 | 1.72 | 12.10 | 19.19 |
| 2019/12 | 370.03 | 192.84 | 1.92 | 58.27 | 6.35 |
| 2020/12 | 582.94 | 331.90 | 1.76 | 126.20 | 4.62 |
| 2021/12 | 755.57 | 458.15 | 1.65 | 140.56 | 5.38 |
Quarterly PL/CFS/BS
| Date | Revenue | NetIncome | Operating CF | Operating CF Margin | Equity |
|---|
| 2017/12 | 621.3 | 82.7 | 69.35 | 11.2% | 2,930.25 |
| 2018/03 | 551.52 | 656.77 | 40.35 | 7.3% | 4,488.09 |
| 2018/06 | 575.91 | 268.04 | 77.86 | 13.5% | 4,638.95 |
| 2018/09 | 545.14 | 269.33 | 62.28 | 11.4% | 4,900.48 |
| 2018/12 | 616.9 | -828.5 | 105.01 | 17.0% | 4,020.33 |
| 2019/03 | 553.98 | 865.2 | 42.94 | 7.8% | 4,863.85 |
| 2019/06 | 572.62 | 598.81 | 155.4 | 27.1% | 5,486.81 |
| 2019/09 | 560.63 | -258.82 | 99.75 | 17.8% | 5,131.19 |
| 2019/12 | 624.5 | 553.5 | 159.8 | 25.6% | 5,755.06 |
| 2020/03 | 571.64 | 685.91 | 62.81 | 11.0% | 6,293.08 |
| 2020/06 | 536.88 | 966.43 | 92.12 | 17.2% | 7,353.4 |
| 2020/09 | 647.26 | 1,314.82 | 135.66 | 21.0% | 8,825.15 |
| 2020/12 | 789.8 | 839.2 | 284.73 | 36.1% | 9,879.94 |
| 2021/03 | 726.8 | 977.41 | 113.61 | 15.6% | 10,609.06 |
| 2021/06 | 715.93 | 914.11 | 154.62 | 21.6% | 11,594.88 |
| 2021/09 | 747.05 | 3,928.03 | 230.36 | 30.8% | 15,332.38 |
| 2021/12 | 732.8 | -1,573.7 | 157.92 | 21.6% | 13,667.13 |
| 2022/03 | 700.06 | -3,369.61 | 46.31 | 6.6% | 10,182.92 |
| 2022/06 | 691.1 | -927.18 | 50.2 | 7.3% | 8,922.6 |
| 2022/09 | 680.8 | -164.23 | 7.51 | 1.1% | 8,453.6 |
Quarterly Indicators
| Date | Stock Price | BPS | PBR | EPS(Quarterly) | PER(Annual conversion) | Outstanding Stocks |
|---|
| 2017/12 | 238.67 | 98.81 | 2.42 | 2.75 | 21.70 | 29.655 |
| 2018/03 | 250.08 | 150.67 | 1.66 | 21.77 | 2.87 | 29.787 |
| 2018/06 | 288.54 | 155.66 | 1.85 | 8.87 | 8.13 | 29.801 |
| 2018/09 | 312.99 | 164.32 | 1.90 | 8.89 | 8.80 | 29.822 |
| 2018/12 | 232.22 | 134.75 | 1.72 | -27.73 | minus | 29.836 |
| 2019/03 | 305.68 | 163.21 | 1.87 | 28.74 | 2.66 | 29.801 |
| 2019/06 | 312.59 | 184.08 | 1.70 | 19.86 | 3.93 | 29.807 |
| 2019/09 | 332.74 | 172.10 | 1.93 | -8.68 | minus | 29.815 |
| 2019/12 | 370.03 | 192.84 | 1.92 | 18.31 | 5.05 | 29.843 |
| 2020/03 | 350.56 | 210.72 | 1.66 | 22.72 | 3.86 | 29.865 |
| 2020/06 | 451.49 | 247.10 | 1.83 | 32.15 | 3.51 | 29.759 |
| 2020/09 | 515.46 | 296.68 | 1.74 | 43.64 | 2.95 | 29.746 |
| 2020/12 | 582.94 | 331.90 | 1.76 | 27.81 | 5.24 | 29.768 |
| 2021/03 | 571.17 | 355.73 | 1.61 | 32.38 | 4.41 | 29.823 |
| 2021/06 | 644.29 | 389.18 | 1.66 | 30.32 | 5.31 | 29.793 |
| 2021/09 | 745.95 | 514.51 | 1.45 | 129.96 | 1.43 | 29.8 |
| 2021/12 | 755.57 | 458.15 | 1.65 | -52.59 | minus | 29.831 |
| 2022/03 | 563.23 | 340.19 | 1.66 | -112.57 | minus | 29.933 |
| 2022/06 | 495.00 | 298.78 | 1.66 | -31.12 | minus | 29.863 |
| 2022/09 | 417.14 | 283.50 | 1.47 | -5.52 | minus | 29.819 |
About The Unit
- Revenue,NetIncome,Operating CashFlow,Assets,StockHolder's Equity : Million Dollars
- StockPrice,BPS,EPS,DPS : One USD
- Outstanding Stocks : Million Stocks
- PPBR,PER: Integer multiple